The analysts have too high estimates on purpose. They miss 1-3 c (which doesn't really matter) and they make a sell off to get cheap shares before highly predicted good 3ph results.
Retail investors could use this opportunity to enter or add. Or will they ever learn?!!!
I'm curious to see the numbers. I think we will see a growth in line with our guidance but the problem is that analysts estimates are slightly higher.. my fear here is that a good quarter may not be appreciated by the market. My view is 51/52M revenues for this quarter; on 5 Nov, after Depo cc, we can better understand where we are going.
However if we see numbers in line with consensus probably the company will raise the guidance.